Higher dose Proton Pump Inhibitors (PPIs) by all Sub-ICB Locations
Why it matters: PPIs are used to reduce acid levels in the stomach, in order to treat conditions such as gastro-oesophageal reflux disease. NICE guidance recommends that the lowest dose is used to treat the symptoms. Although PPIs are safe drugs, their use has been associated with an increase in a number of disorders, including Clostridium difficile infection and a higher risk of community-aquired pneunmonia. This measure looks at strengths of PPIs issued that exceed the low doses of PPIs defined in the NICE guidance.
Description: Prescribing of higher dose Proton Pump Inhibitors compared with prescribing of all PPIs (excluding liquids)
Explore:
Tagged as: Standard, Gastrointestinal system, NICE, Safety (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →
Fetching data...